echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > High-value consumables: the highest reduction of 96% Leading enterprises Strong Hengqiang, dealer pressure mountain.

    High-value consumables: the highest reduction of 96% Leading enterprises Strong Hengqiang, dealer pressure mountain.

    • Last Update: 2020-09-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical network September 9th, high-value consumables belt volume collection normalization, the decline is obvious at present, medical supplies belt volume procurement has been the trend.
    countries have also been releasing strong policy guidance to promote the normalization of centralized procurement.
    with the continuous progress of provincial or provincial alliance collection, from the point of view of the decline achieved good results, to artificial crystals, crown balloons, crown stents as an example.
    1, artificial crystals up to now, artificial crystals have become the country's highest volume procurement coverage of varieties.
    as of September 2020, there were six volume procurement projects involving artificial crystals, including two provincial alliance projects, three provincial projects and one municipal project. The
    project covers 22 provinces, including Anhui, Jiangsu, Beijing, Tianjin, Hebei, Liaoning, Jilin, Heilongjiang, Shanxi, Inner Mongolia, Shandong, Ningxia, Gansu, Qinghai, Xinjiang, Xinjiang Construction Corps, Hunan, Guangxi, Guizhou, Hainan, Shaanxi, Yunnan Qujing and Shanghai, accounting for 70.97 percent of the country's 31 provinces (cities and districts).
    From the published results of the negotiations, Anhui's average negotiating decline was 20.5%, Jiangsu's average decline was about 26.89 percent, the highest decline of 38 percent, and the Beijing-Tianjin-Hebei "3 plus 6" alliance negotiations, the average decline of about 53.72 percent, the highest decline of 84.21 percent.
    2, as of September 2020, a total of 5 procurement projects involving crown balloons, covering Guizhou, Chongqing, Hainan, Hubei, Yunnan, Jiangsu, Zhejiang, Hunan and other provinces.
    from the published results of the negotiations, the average decline in negotiations in Yunnan was more than 70%, the average decline in Jiangsu was 74.37%, the largest decrease was 81.05%, the highest decline in Hubei Province was 96%, and the pre-union of yuyu-jong 3 provinces The average decline of the expansion group was 85.49 percent, the highest decline was 89.84 percent, and the average decline of the later expansion group was 85.15 percent, the highest decrease was 90.35 percent, and the overall decline was 85.32 percent.
    3, crown bracket as of September 2020, involving the crown vein bracket with a total of 4 procurement projects, involving Jiangsu, Shanxi and other provinces.
    the results of the published negotiations, Jiangsu Province saw an average decline of 51.01 per cent, with a maximum decline of 66.07 per cent, while Shanxi Province saw an average decline of 52.98 per cent and a maximum decline of 69.12 per cent.
    of high-value consumables national collection bracket first, the fastest or in September after the drug national collection, high-value consumables national collection has been arrow in the string.
    first batch of state-level high-value consumables collection will start from the crown vein bracket.
    as soon as September, according to industry analysts.
    of this year, the Medical Price and Tender Guidance Center of the State Administration of Medical Security issued a letter of request for comments on the commissioning of the "National Organization's Crown Bracket Centralized Belt Purchase Program (Draft for Comments).
    this national harvest will start from the crown vein bracket, explore the development of national organizations of high-value medical supplies centralized belt procurement.
    the materials involved are cobalt chromium alloy and platinum chromium alloy, the drug-carrying type is repamycin or derivatives, the drug carrier coating properties of non-Teflon coronary stent.
    the Joint Procurement Office for High-Value Medical Supplies, which is responsible for the development of specific technical indicators.
    the procurement period is 2 years, after the expiration of the agreement, the provinces to determine the supply enterprises, agreed procurement volume and procurement period.
    major changes in supply and demand, technical level and market pattern, the selected enterprise, the selected price and the agreed purchase quantity may be generated by means of bidding, bargaining, negotiation and inquiry.
    the scope and quantity of procurement, this volume procurement is currently the largest procurement alliance ever.
    program mentions that in 2019, more than 1000 public medical institutions and military medical institutions with more than 1000 crown stents should participate, and other public medical institutions, military medical institutions and designated social medical institutions for medical insurance should participate voluntarily in accordance with the arrangements of their provinces.
    provinces where centralized procurement of such products has been carried out and is still within the contract period may not participate.
    in the agreed purchase volume ratio, the medical institutions involved in the alliance procurement report the total procurement base and the purchase base of each product (excluding stainless steel brackets) according to the 2019 purchase volume.
    agreed on the purchase volume according to 80% of the total procurement base, and ensure that the purchase volume of each selected product is not less than 80% of the declared procurement base.
    At present, the crown bracket field has basically completed the domestic replacement, including major foreign-funded enterprises including Medtron, Boston Science, Johnson and Johnson, etc., in the domestic market share of less than 30%, the main domestic enterprises including micro-creative, Lepu, Jiwei, Sano and so on, the total market share of domestic manufacturers has exceeded 70%.
    the highest market share of minimally invascopic medical products, in the lead position of the crown stent.
    it is worth noting that Sano Medical's products are all made of stainless steel, do not meet the procurement conditions, the other three companies are eligible for the main products, are eligible to participate in the collection.
    photo source: Medical equipment collection continued to advance, benefiting domestic leading enterprises high-value consumables collection continued to advance, will accelerate domestic substitution from at least two dimensions.
    , the price reduction will lead to a sharp compression of foreign profits, so that it changes the competitive strategy.
    huge profits in the past have led to foreign investment not in the domestic market fine management.
    there are currently some import enterprises through cooperation with domestic enterprises to continue to seek survival space.
    , on the other hand, the proportion of out-of-label products after the implementation of the collection will be greatly compressed, and the high-end products of foreign investment and the probability is that the out-of-standard products.
    when the volume of off-standard products is compressed, the final shipment can not maintain logistics and warehousing costs, will make foreign investment forced out.
    orthopaedic implants as an example, orthopaedic medical devices can be divided into trauma, spine, joints and others according to the types of diseases treated.
    It is understood that the field of trauma has basically completed import substitution, followed by the spine market, compared to trauma and spine products, artificial joint equipment is a permanent implant product, high technical threshold, difficult manufacturing process and difficult surgery, import replacement speed is relatively slow, the lowest degree of localization, up to 26.73 percent.
    industry pointed out that with volume procurement or will accelerate the domestic enterprises in the spine and trauma area of the market share, the industry will have the scale advantage, advanced technology, innovation iteration of the head of enterprises concentrated.
    prices fall further, or no more dealers earn high-value medical supplies because of its technical content, clinical value, academic promotion and market cultivation and other factors, resulting in high market prices.
    of high-value consumables is constantly being squeezed.
    industry analysis, it is expected that after the purchase of consumables, the business model will change significantly.
    Because of the high unit price of high-value consumables, the difference between the factory price and the terminal price is larger, there is more "water" in the channel, but with the cooperation of the two-vote system and the one-vote system, the moisture of the consumables will be compressed again.
    that is, the collection of price reduction space is mostly borne by dealers.
    addition, the promotion of medical device products need more multi-level distribution system, resulting in small and decentralized device dealers.
    with the introduction of one-vote system, or to enable production enterprises to participate in the hospital supply chain management, so that dealers gradually disappear.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.